Dioseve | RoundOS

Weekly digest by email

Loading companies…

Dioseve | RoundOS

Weekly digest by email

Funding history

1 round · 1 with disclosed amounts

Announced	Round	Amount	Investors
Jun 16, 2026	Series A+	$7M	Archetype Ventures — Role not disclosedD4V — Role not disclosedDG Daiwa Ventures — Role not disclosedMirai Door (Asuka Innovation Fund) — Role not disclosedPangaea Ventures — Role not disclosedShionogi & Co — Role not disclosed

Investors

Archetype VenturesSeries A+D4VSeries A+DG Daiwa VenturesSeries A+Mirai Door (Asuka Innovation Fund)Series A+Pangaea VenturesSeries A+Shionogi & CoSeries A+

Coverage

Jun 16, 2026Dioseve · Series A+

Similar companies

AusperBioDevelops oligonucleotide therapeutics targeting chronic hepatitis B$120M · Series C

MetriportOpen-source healthcare data infrastructure unifying patient records for clinicians$26M · Series A

ProFound TherapeuticsUses AI and proteomics to discover drug targets and biomarkers for preeclampsia and eclampsia$35M · Strategic

Sources

dioseve.com ↗